Keywords: |
protein expression; protein phosphorylation; unclassified drug; gene mutation; genetics; nonhuman; note; gemcitabine; metabolism; antimetabolites, antineoplastic; drug effect; drug resistance; drug resistance, neoplasm; cell line, tumor; gene expression regulation; gene expression regulation, neoplastic; cytidine deaminase; genomic instability; tumor cell line; innate immunity; upregulation; single stranded dna; up-regulation; cellular stress response; deoxycytidine; antineoplastic antimetabolite; mutagenesis; chromosome 22; pancreatic ductal carcinoma; translesion synthesis; humans; human; crispr-cas9 system; apolipoprotein b mrna editing enzyme catalytic polypeptide like; apobec3a protein; apobec3b protein; doxecitine; apobec deaminases; apobec3 protein; apobec3c protein; apobec3d protein; apobec3 proteins, human
|